Next Article in Journal
A Novel Approach to Critical Congenital Heart Disease (CCHD) Screening at Moderate Altitude
Next Article in Special Issue
The Further Adventures of Newborn Screening for Biotinidase Deficiency: Where It Is at and What We Still Need to Know
Previous Article in Journal
A Rapid and Sensitive UPLC-MS/MS-Method for the Separation and Quantification of Branched-Chain Amino Acids from Dried Blood Samples of Patients with Maple Syrup Urine Disease (MSUD)
Article Menu

Export Article

Open AccessTechnical Note
Int. J. Neonatal Screen. 2016, 2(3), 3; doi:10.3390/ijns2030003

A Non-Invasive Strategy for Neonatal Alloimmune Thrombocytopenia Diagnosis: Newborn Platelet Genotyping with Buccal Swabs

1
EFS Bretagne, HLA-HPA Laboratory, Rue Pierre-Jean Gineste, BP91614, 35016 Rennes Cedex, France
2
Platelet Immunology Laboratory, Institut National de la Transfusion Sanguine (INTS), 75739 Paris, France
This author is retired.
*
Author to whom correspondence should be addressed.
Academic Editor: Harvey L. Levy
Received: 9 June 2016 / Revised: 24 June 2016 / Accepted: 29 June 2016 / Published: 4 July 2016
(This article belongs to the Special Issue Newborn Screening-Past, Present and Future)
View Full-Text   |   Download PDF [442 KB, uploaded 4 July 2016]   |  

Abstract

Neonatal alloimmune thrombocytopenia results from the maternal immune response against fetal-specific antigens inherited from the father. The diagnosis is ascertained only when the maternal alloantibody and the offending antigen present in the newborn are identified. Up until now most laboratories perform DNA extraction for neonatal genotyping from newborn blood samplings. In order to avoid such an invasive procedure, two protocols of DNA extraction from buccal swabs were developed: a manual protocol using the QIAamp mini blood kit (Qiagen), and an automated procedure with the MagNA Pure Compact instrument (Roche). Both EDTA-blood and buccal swabs from thrombocytopenic newborns were genotyped manually (14 samples), automatically (15 samples) or both manually and automatically (two samples). Human Platelet Antigen (HPA) genotyping was performed using the BeadChip assay (BioArray, Immucor). Concordant genotypings were obtained for all samples except for one swab with the manual method. The automated DNA extraction from newborn buccal swabs with the MagNA Pure Compact instrument was chosen as the first-line strategy, with a significant gain of time in processing buccal swabs. View Full-Text
Keywords: neonatal alloimmune thrombocytopenia (NAIT); Human Platelet Antigen (HPA); genotyping; buccal swab; DNA extraction neonatal alloimmune thrombocytopenia (NAIT); Human Platelet Antigen (HPA); genotyping; buccal swab; DNA extraction
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Bertrand, G.; Kaplan, C. A Non-Invasive Strategy for Neonatal Alloimmune Thrombocytopenia Diagnosis: Newborn Platelet Genotyping with Buccal Swabs. Int. J. Neonatal Screen. 2016, 2, 3.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Neonatal Screen. EISSN 2409-515X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top